Resolvin E1 and Resolvin E2 suppress cyclooxygenase-2 expression through ubiquitin-proteasome-mediated degradation in human macrophage-like U937 cells
- 16 February 2026
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 183, 107064
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency
This publication has 46 references indexed in Scilit:
- Aspirin-based PROTACs as COX-2 degraders for anti-inflammationBioorganic & Medicinal Chemistry, 2025
- Activity-dependent COX-2 proteolysis modulates aerobic respiration and proliferation in a prostaglandin-independent manneriScience, 2024
- Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial RepairCellular and Molecular Gastroenterology and Hepatology, 2022
- Omega-3 polyunsaturated fatty acids as an angelus custos to rescue patients from NSAID-induced gastroduodenal damageJournal of Gastroenterology, 2015
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitisInflammatory Bowel Diseases, 2010
- The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibsJournal of Molecular Medicine, 2007
- Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradationProgress in Lipid Research, 2007
- The Role of Cyclooxygenase in Gastric Mucosal ProtectionDigestive Diseases and Sciences, 2005
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995